18
Participants
Start Date
January 16, 2025
Primary Completion Date
March 19, 2026
Study Completion Date
April 8, 2032
Elafibranor
Tablet of 80 mg
RECRUITING
Nippon Medical School - Chiba Hokusoh Hospital, Chiba
RECRUITING
Fukushima Medical University Hospital, Fukushima
RECRUITING
Chugoku Rosai Hospital, Hiroshima
RECRUITING
Teine Keijinkai Hospital, Hokkaido
RECRUITING
Kagawa University Hospital, Kagawa
RECRUITING
Kagoshima University Hospital, Kagoshima
RECRUITING
Shinshu University Hospital, Nagano
RECRUITING
National Hospital Organization Nagasaki Medical Center, Nagasaki
RECRUITING
Nara Medical University Hospital, Nara
RECRUITING
Nagaoka Red Cross Hospital, Niigata
RECRUITING
Niigata University Medical & Dental Hospital, Niigata
RECRUITING
National Hospital Organization Osaka National Hospital, Osaka
RECRUITING
Hamamatsu University Hospital, Shizuoka
RECRUITING
Juntendo University Hospital, Tokyo
RECRUITING
Teikyo University Hospital, Tokyo
RECRUITING
Tokyo Metropolitan Komagome Hospital, Tokyo
Lead Sponsor
Ipsen
INDUSTRY